KKR sold off its 46.39% stake in J.B. Chemicals and Pharmaceuticals to Torrent Pharma after grooming the Indian drugmaker ...

An exclusive look at newly-formed Altaline Capital Management, a Los Angeles based PE shop focusing on the lower midmarket, ...

Based in Los Angeles, the firm was founded by Ian Balmaseda, who was formerly at HIG Capital, where he was on its LBO Funds ...

Private-equity firm KKR has launched a new financial advisory platform in Singapore, aiming to support firms in enhancing their technology and strengthening customer management. The platform, Ascend ...

Private equity firm KKR & Co Inc said on Monday that its Ascend Asia Financial Services Group is acquiring a financial ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $136.8, a high ...

The private equity industry has experienced a notable shift with a growing wave of high-profile public listings worldwide.

Proskauer Rose recruited a Paul Weiss partner who started Monday leading the firm’s US private equity transactions practice.

KKR & Co. Inc. (NYSE:KKR) one of the best stocks in a Growth Stock Portfolio. Recently, on June 24, 2025, Assura Group, based ...

Private equity firm KKR has agreed to sell its entire stake in India-listed J.B. Chemicals & Pharmaceuticals for $1.4 billion. Under the deal, KKR will sell its 46.39% stake to Torrent Pharmaceuticals ...

According to the terms announced Sunday, Torrent will purchase a 46.4% interest in JB Pharma at 1,600 rupees ($18.70) per ...